Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 277

1.

Cancer risk among participants in the women's interagency HIV study.

Hessol NA, Seaberg EC, Preston-Martin S, Massad LS, Sacks HS, Silver S, Melnick S, Abulafia O, Levine AM; WIHS Collaborative Study Group.

J Acquir Immune Defic Syndr. 2004 Aug 1;36(4):978-85.

PMID:
15220706
2.

Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.

Clifford GM, Polesel J, Rickenbach M, Dal Maso L, Keiser O, Kofler A, Rapiti E, Levi F, Jundt G, Fisch T, Bordoni A, De Weck D, Franceschi S; Swiss HIV Cohort.

J Natl Cancer Inst. 2005 Mar 16;97(6):425-32.

PMID:
15770006
3.

Cancer incidence in the multicenter AIDS Cohort Study before and during the HAART era: 1984 to 2007.

Seaberg EC, Wiley D, Martínez-Maza O, Chmiel JS, Kingsley L, Tang Y, Margolick JB, Jacobson LP; Multicenter AIDS Cohort Study (MACS).

Cancer. 2010 Dec 1;116(23):5507-16. doi: 10.1002/cncr.25530. Epub 2010 Jul 29.

4.

Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults.

International Collaboration on HIV and Cancer.

J Natl Cancer Inst. 2000 Nov 15;92(22):1823-30.

PMID:
11078759
5.

Underestimation of relative risks by standardized incidence ratios for AIDS-related cancers.

Chaturvedi AK, Mbulaiteye SM, Engels EA.

Ann Epidemiol. 2008 Mar;18(3):230-4.

PMID:
18083545
6.

HIV as a risk factor for lung cancer in women: data from the Women's Interagency HIV Study.

Levine AM, Seaberg EC, Hessol NA, Preston-Martin S, Silver S, Cohen MH, Anastos K, Minkoff H, Orenstein J, Dominguez G, Watts DH.

J Clin Oncol. 2010 Mar 20;28(9):1514-9. doi: 10.1200/JCO.2009.25.6149. Epub 2010 Feb 22.

7.

Cancer risk in people infected with human immunodeficiency virus in the United States.

Engels EA, Biggar RJ, Hall HI, Cross H, Crutchfield A, Finch JL, Grigg R, Hylton T, Pawlish KS, McNeel TS, Goedert JJ.

Int J Cancer. 2008 Jul 1;123(1):187-94. doi: 10.1002/ijc.23487.

8.

Human immunodeficiency virus infection, aging, and cancer.

Engels EA.

J Clin Epidemiol. 2001 Dec;54 Suppl 1:S29-34. Review.

PMID:
11750207
9.

Incidence of non-AIDS-defining cancers before and during the highly active antiretroviral therapy era in a cohort of human immunodeficiency virus-infected patients.

Herida M, Mary-Krause M, Kaphan R, Cadranel J, Poizot-Martin I, Rabaud C, Plaisance N, Tissot-Dupont H, Boue F, Lang JM, Costagliola D.

J Clin Oncol. 2003 Sep 15;21(18):3447-53.

PMID:
12972519
10.

HIV-related malignancies: community-based study using linkage of cancer registry and HIV registry data.

Cooksley CD, Hwang LY, Waller DK, Ford CE.

Int J STD AIDS. 1999 Dec;10(12):795-802.

PMID:
10639060
11.

Non-Hodgkin lymphoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy.

Polesel J, Clifford GM, Rickenbach M, Dal Maso L, Battegay M, Bouchardy C, Furrer H, Hasse B, Levi F, Probst-Hensch NM, Schmid P, Franceschi S; Swiss HIV Cohort Study.

AIDS. 2008 Jan 11;22(2):301-6.

PMID:
18097233
12.

Highly active antiretroviral therapy and the incidence of non-AIDS-defining cancers in people with HIV infection.

Powles T, Robinson D, Stebbing J, Shamash J, Nelson M, Gazzard B, Mandelia S, Møller H, Bower M.

J Clin Oncol. 2009 Feb 20;27(6):884-90. doi: 10.1200/JCO.2008.19.6626. Epub 2008 Dec 29.

PMID:
19114688
13.

Cancer burden in the HIV-infected population in the United States.

Shiels MS, Pfeiffer RM, Gail MH, Hall HI, Li J, Chaturvedi AK, Bhatia K, Uldrick TS, Yarchoan R, Goedert JJ, Engels EA.

J Natl Cancer Inst. 2011 May 4;103(9):753-62. doi: 10.1093/jnci/djr076. Epub 2011 Apr 11.

14.

Antiretroviral therapy exposure and incidence of diabetes mellitus in the Women's Interagency HIV Study.

Tien PC, Schneider MF, Cole SR, Levine AM, Cohen M, DeHovitz J, Young M, Justman JE.

AIDS. 2007 Aug 20;21(13):1739-45.

PMID:
17690572
15.
16.

Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.

Huang KP, Weinstock MA, Clarke CA, McMillan A, Hoppe RT, Kim YH.

Arch Dermatol. 2007 Jan;143(1):45-50.

PMID:
17224541
17.

Trends and predictors of non-AIDS-defining cancers in men and women with HIV infection: a single-institution retrospective study before and after the introduction of HAART.

Franzetti M, Adorni F, Parravicini C, Vergani B, Antinori S, Milazzo L, Galli M, Ridolfo AL.

J Acquir Immune Defic Syndr. 2013 Apr 1;62(4):414-20. doi: 10.1097/QAI.0b013e318282a189.

PMID:
23274934
18.

Human immunodeficiency virus-associated primary lung cancer in the era of highly active antiretroviral therapy: a multi-institutional collaboration.

D'Jaen GA, Pantanowitz L, Bower M, Buskin S, Neil N, Greco EM, Cooley TP, Henry D, Stem J, Dezube BJ, Stebbing J, Aboulafia DM.

Clin Lung Cancer. 2010 Nov 1;11(6):396-404. doi: 10.3816/CLC.2010.n.051.

PMID:
21062730
19.

Characteristics of non-AIDS-defining malignancies in the HAART era: a clinico-epidemiological study.

Dauby N, De Wit S, Delforge M, Necsoi VC, Clumeck N.

J Int AIDS Soc. 2011 Mar 28;14:16. doi: 10.1186/1758-2652-14-16.

20.

Non-Hodgkin's lymphoma in patients with human immunodeficiency virus infection in Taiwan.

Yang CJ, Chen MY, Hsieh SM, Sheng WH, Sun HY, Hung CC, Chang SC.

J Microbiol Immunol Infect. 2010 Aug;43(4):278-84. doi: 10.1016/S1684-1182(10)60044-8.

Supplemental Content

Support Center